Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular and Cellular Therapeutics (MCT) is a full-service cGMP manufacturing facility located at the University of Minnesota that operates as a contract development and manufacturing organization (CDMO). The facility specializes in the production of advanced cellular and gene therapy products, including CAR-T cells, mesenchymal stem cells, and microbiota-based therapeutics. MCT provides comprehensive services ranging from process development and validation to clinical-grade manufacturing for Phase I through Phase III clinical trials. It is notably involved in the Production Assistance for Cellular Therapies (PACT) program and supports both academic researchers and commercial biotechnology companies in translating bench-side discoveries into clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular & Cellular Therapeutics.